LoginGet started
Picture of Japan Tissue Engineering Co logo

7774 — Japan Tissue Engineering Co Income Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for Japan Tissue Engineering Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,3582,3102,2582,1032,032
Cost of Revenue
Gross Profit1,2851,1881,1571,2551,137
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses2,7082,5452,7242,6032,761
Operating Profit-350-235-467-500-728
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-340-230-463-494-725
Provision for Income Taxes
Net Income After Taxes-333-287-467-498-729
Net Income Before Extraordinary Items
Net Income-333-287-467-498-729
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-333-287-467-498-729
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-8.21-7.07-11.5-12.2-18
Dividends per Share